DX 9065a

DX 9065a Suppliers list
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: CONIER CHEM AND PHARMA LIMITED  
Tel:
Email: sales@conier.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Company Name: HANGZHOU LEAP CHEM CO., LTD.  
Tel: +86-571-87711850 +86-15355479329
Email: market18@leapchem.com
DX 9065a Basic information
Product Name:DX 9065a
Synonyms:DX 9065a;(alphaS)-7-(Aminoiminomethyl)-alpha-[4-[[(3S)-1-(1-iminoethyl)-3-pyrrolidinyl]oxy]phenyl]-2-naphthalenepropanoic acid hydrochloride hydrate;2-Naphthalenepropanoic acid, 7-(aMinoiMinoMethyl)-α-[4-[[(3S)-1-(1-iMinoethyl)-3-pyrrolidinyl]oxy]phenyl]-, (Hydrochloride), hydrate (1:1:5), (αS)-;X-9065a;LJCBAPRMNYSDOP-LVCYMWGESA-N;DX-9065a Hydrochloride Pentahydrate;DX 9065;DX9065
CAS:155204-81-2
MF:C26H31ClN4O4
MW:499.01
EINECS:
Product Categories:
Mol File:155204-81-2.mol
DX 9065a Structure
DX 9065a Chemical Properties
Safety Information
MSDS Information
DX 9065a Usage And Synthesis
UsesDX-9065a Hydrochloride Pentahydrate is used in the methods for cell transplantation therapy and use of factor Xa inhibitors for inhibiting the procoagulant activity associated with cell transplantation.
in vivo

After i.v. injection to rabbits, DX-9065a displays prolonged anti-factor Xa activity and inhibition of thrombin generation[1].
After p.o. administration, DX-9065a causes a reduction in tissue factor-induced mortality of mice with ED50 value of 56 mg/kg[1].
When given i.v. to rats, DX-9065a exhibits a dose-dependent antithrombotic effect against factor Xa + stasis-induced venous thrombosis (ED50 = 1.2 mg/kg i.v.), but also in an arteriovenous shunt thrombosis model (ED50 = 8.1 mg/kg i.v.) without affecting bleeding time significantly. Similar effects were obtained after s.c. or p.o. administration[1].
In rabbits, after i.v., s.c. or p.o. administration, DX-9065a inhibits stasis-induced thrombosis after injection of tissue factor with ED50 values of 0.03 mg/kg, 0.3 mg/kg and 50.5 mg/kg, respectively. DX-9065a inhibits in a dose-dependent manner endotoxin-induced venous thrombosis in the rabbit (ED50 = 0.25 mg/kg i.v.) and reduces the decrease in platelet number and circulating fibrinogen levels in an experimental model of tissue factor-induced disseminated intravascular coagulation[1].

DX 9065a Preparation Products And Raw materials
Tag:DX 9065a(155204-81-2) Related Product Information
DX 9065a 2-Naphthalenepropanoic acid, 7-(aminoiminomethyl)-α-[4-[[(3S)-1-(1-iminoethyl)-3-pyrrolidinyl]oxy]phenyl]-, (αS)- Betrixaban Boc-Ile-Glu-Gly-Arg-AMC acetate salt Abelacimab SAR439774